The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $32.90 in the prior trading day, Harmony Biosciences Holdings Inc (NASDAQ: HRMY) closed at $32.47, down -1.31%. In other words, the price has decreased by -$1.31 from its previous closing price. On the day, 0.75 million shares were traded.
Ratios:
Our goal is to gain a better understanding of HRMY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.42. For the most recent quarter (mrq), Quick Ratio is recorded 3.63 and its Current Ratio is at 3.67. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.22.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $55.
On December 17, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $75.H.C. Wainwright initiated its Buy rating on December 17, 2024, with a $75 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 10 ’25 when JEFFREY G DIERKS bought 5,615 shares for $35.98 per share.
JEFFREY G DIERKS bought 9,844 shares of HRMY for $350,083 on May 19 ’25. On May 16 ’25, another insider, JEFFREY G DIERKS, who serves as the Former Officer of the company, bought 2,292 shares for $35.09 each.
Valuation Measures:
As of this moment, Harmony’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.38, and their Forward P/E ratio for the next fiscal year is 8.10. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.50 while its Price-to-Book (P/B) ratio in mrq is 2.59.
Stock Price History:
Over the past 52 weeks, HRMY has reached a high of $41.61, while it has fallen to a 52-week low of $26.47. The 50-Day Moving Average of the stock is 0.59%, while the 200-Day Moving Average is calculated to be -6.14%.
Shares Statistics:
A total of 57.39M shares are outstanding, with a floating share count of 43.61M. Insiders hold about 24.06% of the company’s shares, while institutions hold 78.52% stake in the company.
